These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

593 related items for PubMed ID: 10275461

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Are PPOs a competitive force or antitrust risk?
    Enders RJ.
    Healthc Financ Manage; 1986 May; 40(5):52-60. PubMed ID: 10276171
    [Abstract] [Full Text] [Related]

  • 3. Understanding antitrust: focus on the relevant market.
    Enders RJ.
    Healthc Financ Manage; 1986 Feb; 40(2):25-32. PubMed ID: 10275004
    [Abstract] [Full Text] [Related]

  • 4. Reducing antitrust liability after Maricopa.
    Walsh JH, Feller H.
    GHAA J; 1986 Feb; 7(2):57-74. PubMed ID: 10280126
    [No Abstract] [Full Text] [Related]

  • 5. Antitrust issues in the health care field: an introduction.
    Bressler HJ.
    J Health Hosp Law; 1990 Apr; 23(4):97-100, 114. PubMed ID: 10104711
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. One man's cooperative venture is another man's antitrust suit.
    Bills JC.
    Trustee; 1990 Feb; 43(2):24. PubMed ID: 10104267
    [No Abstract] [Full Text] [Related]

  • 8. Minimizing antitrust and corporate liability risks.
    Weissburg C.
    Health Prog; 1987 Apr; 68(3):68-73, 90. PubMed ID: 10282282
    [Abstract] [Full Text] [Related]

  • 9. The antitrust perspective on health industry competition.
    Miller FH.
    J Health Hum Resour Adm; 1989 Apr; 12(1):128-48. PubMed ID: 10296433
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluating antitrust risk in joint provider negotiations with payors.
    Leonard EJ.
    Med Staff Couns; 1992 Apr; 6(1):41-7. PubMed ID: 10115450
    [Abstract] [Full Text] [Related]

  • 12. The 1996 Justice Department/FTC statements on physician joint ventures and multiprovider organizations.
    Hoffmann ER.
    Med Interface; 1997 Feb; 10(2):103-6. PubMed ID: 10164786
    [Abstract] [Full Text] [Related]

  • 13. Exclusive contracts under antitrust attack.
    Reed TJ, Allen HS.
    Hosp Med Staff; 1982 Nov; 11(11):2-9. PubMed ID: 10257181
    [Abstract] [Full Text] [Related]

  • 14. Joint ventures in health care: more than a sideline business.
    Kaufman K, Hall M, Higgins D.
    Healthc Financ Manage; 1986 May; 40(5):68-74. PubMed ID: 10276173
    [Abstract] [Full Text] [Related]

  • 15. Prognosis: prison? Health care providers, as they set up new business arrangements in this era of rising medical costs, risk running afoul of federal antitrust and antifraud laws.
    Kosterlitz J.
    Natl J (Wash); 1989 Jun 17; 21(24):1576-7, 1582-4. PubMed ID: 10293560
    [No Abstract] [Full Text] [Related]

  • 16. Antitrust implications of joint negotiations with third party payers.
    Rainer JM.
    Top Health Care Financ; 1986 Jun 17; 13(2):79-85. PubMed ID: 3810649
    [No Abstract] [Full Text] [Related]

  • 17. Physician-operated networks and the new antitrust guidelines.
    Kuttner R.
    N Engl J Med; 1997 Jan 30; 336(5):386-91. PubMed ID: 9011808
    [No Abstract] [Full Text] [Related]

  • 18. Provider-sponsored ADSs: reducing antitrust liability after Maricopa.
    Walsh JH, Feller H.
    Spec Law Dig Health Care (Mon); 1985 Apr 30; 7(2):5-25. PubMed ID: 10270877
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.